GlassScriptPhysician profile
Barry Knezek
NPI 1447473541
$714.15
in general payments reported to CMS, 2019-2025
9 companies · $39.28 in 2025
The $39.28 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $65.37 · 2023: $13.85 · 2024: $102 · 2025: $39.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $251.84 | 2019-2020 | |
| Lundbeck LLC | $147.25 | 2019-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $88.18 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.44 | 2019-2024 | Trintellix |
| Adlon Therapeutics L.P. | $41.16 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $40.00 | 2019 | |
| Shire North American Group INC | $29.83 | 2019 | |
| Jazz Pharmaceuticals INC. | $25.17 | 2019 | |
| Bausch Health US, LLC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Knezek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.